Link Technologies Ltd Release: Unlocking the Potential of Cell Delivery Agents

Published: Sep 27, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BELLSHILL, SCOTLAND, 27 September 2013: Link Technologies Ltd, an ISO 9001:2008 certified specialist oligonucleotide reagent manufacturer, will be presenting a poster at the upcoming 9th Annual Meeting of the Oligonucleotide Therapeutic Society (OTS), 6-8 October, Naples, Italy. The poster entitled ‘New Potential Oligonucleotide Delivery Reagents’, details how Link Technologies’ novel modifiers can enable the enhanced delivery of oligos for therapeutic effect. Inspired by their existing collection of lipophilic modifiers, which have been proven to enhance cell penetration, Link Technologies has developed this new collection of modified phosphoramidites, and are inviting collaborative partners to help discover their full application potential. At OTS, Dr Catherine McKeen, Technical Manager at Link Technologies, will be on-hand throughout the poster presentation sessions to provide further information and answer any questions.

For more information on Link Technologies and our enabling lipophilic modifiers for cell delivery, please attend our poster presentation at OTS or request a free copy of our 2013/14 Product Guide. Providing comprehensive information for scientists working with modified oligos, including validated protocols and supporting application notes, the new product guide is an ideal go-to resource for oligonucleotide chemistry.

Alternatively, please visit the website at or follow us on Twitter: @linktechdna.

About Link Technologies Ltd

Link Technologies Ltd is a leading kilo-scale supplier of speciality reagents for oligonucleotide synthesis and modification, all to the ISO 9001:2008 quality certification. The company’s main markets are university and commercial research departments, plus, increasingly, larger Contract Manufacturing Organisations (CMOs) in the biotech sector. Link has also forged successful links to academia working closely with many UK universities. In tandem with internal research and development, the Company has an excellent record in bringing in-licence products to market with various worldwide commercial partners.

For further information see:

Help employers find you! Check out all the jobs and post your resume.

Back to news